Millipore Sigma Vibrant Logo

178461 Apolipoprotein C-III, Human Plasma, Very Low-Density Lipoprotein

Native Apolipoprotein C-III from human plasma found in VLDL and chylomicrons. Involved in triglyceride uptake by cells. Inhibits lipoprotein lipase and uptake of lipoprotein remnants by the liver.

Apolipoprotein C-III, Human Plasma, Very Low-Density Lipoprotein: のSDS（安全データシート）、CoA（試験成績書）およびCoQ（品質証明書）、カタログなど製品関連の技術資料を入手いただけます。

同義語: Apo C-III

View This Product on Sigma-Aldrich
178461
価格＆在庫状況を照会

概要

Replacement Information

価格＆在庫状況

カタログ番号 在庫状況包装 Qty/Pk 価格 数量
178461-100UGCN
在庫状況検索中…
—
現在国内在庫なし 現在国内在庫なし
現在国内在庫有り 
販売中止
在庫僅少
現在国内在庫あり
    Remaining : Will advise
      Remaining : Will advise
      注文対象外
      お問合せください
      Contact Customer Service

      		 樹脂ｱﾝﾌﾟﾙ 100 μg
      価格を検索中…
      価格が見つかりません
      Minimum Quantity needs to be mulitiple of
      Maximum Quantity is
      弊社照会 詳細を表示　
      値引
      ()
       
      —
      弊社照会
      		 —
      Description
      OverviewNative apolipoprotein C-III from human plasma. Major protein of VLDL and chylomicrons. Involved in the uptake of triglycerides by cells. May inhibit the activation of lipoprotein lipase by Apo C-II. Present in normal plasma at 80-150 µg/ml.
      Catalogue Number178461
      Brand Family Calbiochem®
      SynonymsApo C-III
      References
      ReferencesBonnet, E., et al. 2001. J. Clin. Endocrinol. Metab. 86, 296.
      Hasse, R., et al. 1998. Electrophoresis 9, 569.
      Catapano, A.L., et al. 1978. J. Lipid Res. 19, 1047.
      Product Information
      FormLiquid
      FormulationIn 10 mM NH₄HCO₃, pH 7.4.
      Quality LevelMQ100
      Applications
      Biological Information
      Purity≥95% by SDS-PAGE
      SourcePrepared from plasma that has been shown by certified tests to be negative for HBsAg and for antibodies to HIV and HCV.
      Concentration Label Please refer to vial label for lot-specific concentration
      Physicochemical Information
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Dry Ice Only
      Toxicity Standard Handling
      Storage -20°C
      Avoid freeze/thaw Avoid freeze/thaw
      Do not freeze Ok to freeze
      Special InstructionsFollowing initial thaw, aliquot and freeze (-20°C).
      Packaging Information
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      カタログ番号 GTIN
      178461-100UGCN 04055977222524

      Documentation

      Apolipoprotein C-III, Human Plasma, Very Low-Density Lipoprotein (M)SDS

      タイトル

      英語版製品安全データシート（(M)SDS） 

      Apolipoprotein C-III, Human Plasma, Very Low-Density Lipoprotein 試験成績書（CoA）

      タイトルロット番号
      178461

      参考資料

      参考資料の概要
      Bonnet, E., et al. 2001. J. Clin. Endocrinol. Metab. 86, 296.
      Hasse, R., et al. 1998. Electrophoresis 9, 569.
      Catapano, A.L., et al. 1978. J. Lipid Res. 19, 1047.
      データシート

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision15-April-2008 RFH
      SynonymsApo C-III
      DescriptionNative apolipoprotein C-III from human plasma. Present in normal plasma at 80-150 µg/ml. Major protein of VLDL and chylomicrons. Involved in the uptake of triglycerides by cells. May inhibit the activation of lipoprotein lipase by Apo C-II.
      FormLiquid
      FormulationIn 10 mM NH₄HCO₃, pH 7.4.
      Concentration Label Please refer to vial label for lot-specific concentration
      SourcePrepared from plasma that has been shown by certified tests to be negative for HBsAg and for antibodies to HIV and HCV.
      Purity≥95% by SDS-PAGE
      Storage Avoid freeze/thaw
      -20°C
      Do Not Freeze Ok to freeze
      Special InstructionsFollowing initial thaw, aliquot and freeze (-20°C).
      Toxicity Standard Handling
      ReferencesBonnet, E., et al. 2001. J. Clin. Endocrinol. Metab. 86, 296.
      Hasse, R., et al. 1998. Electrophoresis 9, 569.
      Catapano, A.L., et al. 1978. J. Lipid Res. 19, 1047.